Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
32
Participants
Timeline
Start Date
October 10, 2014
Primary Completion Date
October 10, 2014
Study Completion Date
May 15, 2017
Conditions
Metastatic Colorectal Cancer
Interventions
DRUG
ANAKINRA
Trial Locations (1)
21079
Centre Georges François Leclerc, Dijon
All Listed Sponsors
lead
Centre Georges Francois Leclerc
OTHER
NCT02090101 - Study Evaluating the Influence of LV5FU2 Bevacizumab Plus Anakinra Association on Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter